Results 81 to 90 of about 106,790 (296)

Serum levels of β-hydroxybutyrate and pyruvate, metabolic changes and cognitive function in patients with schizophrenia during antipsychotic treatment: a preliminary study

Neuropsychiatric Disease and Treatment, 2018
Yu-Chi Huang,1–3 Pao-Yen Lin,1,4 Yu Lee,1 Chi-Fa Hung,1 Su-Ting Hsu,5 Chih-Ching Wu,6,7,* Liang-Jen Wang8,* 1Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan ...
Huang YC, Lin PY, Lee Y, Hung CF, Hsu ST, Wu CC, Wang LJ   +6 more
doaj  

Antipsychotic withdrawal symptoms: Phenomenology and pathophysiology [PDF]

, 1988
Steven C. Dilsaver, N E Alessi
openalex   +1 more source

Antipsicóticos de ação prolongada no tratamento de manutenção da esquizofrenia: Parte I. Fundamentos do seu desenvolvimento, benefícios e nível de aceitação em diferentes países e culturas

Revista Latino-Americana de Enfermagem
Neste trabalho são revistos os fundamentos do desenvolvimento dos antipsicóticos de ação prolongada, a aderência ao tratamento, fatores que dificultam o seguimento da prescrição e suas conseqüências, benefícios e aceitação dos antipsicóticos de ação ...
Luiz Paulo de C. Bechelli
doaj  

Antipsychotic Agents: A Clinical Update [PDF]

, 1985
John L. Black, Elliott Richelson, Jarrett W. Richardson   +2 more
openalex   +1 more source

An Antipsychotic

, 2020
Zyprexa is a trade name of a typical antipsychotic medication called Olanzapine. No one knows how it works. It works by changing some actions of the chemicals on the brain. Zyprexa is mainly used to treat psychotic conditions like maniac depression which is also called a bipolar disorder and schizophrenia. This medication is given to adults and also to
openaire   +1 more source

Personalized multichannel transcranial direct current electrical stimulation (tDCS) in drug‐resistant epilepsy: A SEEG based open‐labeled study

Epilepsia Open, EarlyView.
Abstract Objective To evaluate the effects of personalized multichannel tDCS on seizure frequency, severity, quality of life, and psychiatric comorbidities in patients with drug‐resistant focal epilepsy. Secondary goals include assessing the safety and feasibility of this approach.
Fabrice Bartolomei, Maëva Daoud, Megane Delourme, Sophie Tardoski, Julia Makhalova, Eya Bourguiba, Samuel Medina Villalon, Stanislas Lagarde, Fabrice Wendling, Giulio Ruffini, Ricardo Salvador, Francesca Pizzo, Bernard Giusiano   +12 more
wiley   +1 more source

Rest‐activity rhythm phenotypes in adults with epilepsy and intellectual disability

Epilepsia Open, EarlyView.
Abstract Objective Rest‐activity rhythms (RARs) are perturbed in many forms of neuropsychiatric illness. In this study, we applied wrist actigraphy to describe RAR perturbations in intellectually disabled adults with epilepsy (“E + ID”), using a cross‐sectional case–control design.
Nandani Adhyapak, Grace E. Cardenas, Mark A. Abboud, Vaishnav Krishnan   +3 more
wiley   +1 more source

The Efficacy of Pharmacological Treatment of Depression in Anorexia Nervosa and Underweight Patients: A Systematic Review

European Eating Disorders Review, EarlyView.
ABSTRACT Objective Major depressive disorder (MDD) is a frequent comorbidity in anorexia nervosa (AN). This review aimed to evaluate evidence on the effectiveness of pharmacological treatments for MDD in underweight individuals. Method A systematic review was conducted using PubMed, Medline, PsycINFO, and Web of Science through March 2025.
M. J. Besjes, S. H. W. Mares, A. A. van Elburg, J. Spijker   +3 more
wiley   +1 more source

Regional Considerations in the Use of Antipsychotic Drugs [PDF]

, 1993
Patrick D. McGorry, Guy Chouinard, Ross J. Baldessarini, W. Wolfgang Fleischhacker   +3 more
openalex   +1 more source

Efficacy of Adjunct Olanzapine Treatment in Adolescents With Anorexia Nervosa: A Comparison of Two Patient Cohorts

European Eating Disorders Review, EarlyView.
ABSTRACT Background Anorexia nervosa (AN) is a severe psychiatric disorder with high mortality, requiring innovative treatment strategies. Olanzapine (OLZ), an atypical antipsychotic, has demonstrated efficacy in promoting weight gain and reducing psychopathological symptoms in adults with AN.
Helene Krauss, Michael Zeiler, Dunja Mairhofer, Julia Klang, Julia Schwarzenberg, Michaela Mitterer, Gudrun Wagner, Maria Glüder, Karin Egberts, Manfred Gerlach, Andreas Karwautz   +10 more
wiley   +1 more source